What Is NAD+? Why Does It Decline With Age?

By the mid-40s, most people start noticing things that do not match the version of themselves from a decade earlier. Energy fades earlier in the afternoon. Workouts that used to take a day to recover from take three. Sleep is less restorative even when the hours look right. Mental sharpness slips in small but persistent ways. Some of this is normal aging, but a meaningful fraction traces back to a single molecule that powers nearly every cell in the body and drops sharply with age: NAD+.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It participates in hundreds of enzymatic reactions, with the most important being the conversion of food into cellular energy, the repair of damaged DNA, and the activation of a family of longevity-associated proteins called sirtuins. NAD+ levels fall by roughly 50 percent between age 40 and 60, with continued decline after that. Many of the symptoms commonly chalked up to normal aging, including persistent fatigue, cognitive slowing, reduced exercise capacity, and disrupted sleep, are partially explained by this drop.

What Is NAD+ and What Does It Do in the Cell?

NAD+ functions primarily as an electron carrier in the mitochondrial electron transport chain, the process that produces ATP, the molecule cells use for energy. Every tissue in the body depends on NAD+ for energy production. When NAD+ levels fall, mitochondrial efficiency drops, and cells produce less energy on the same nutritional input. This is one reason fatigue in NAD-depleted individuals does not respond to sleep or eating more food the way ordinary tiredness does. The energy machinery itself has slowed.

Beyond energy metabolism, NAD+ is the required cofactor for sirtuins, a family of enzymes with broad roles in inflammation regulation, stress resistance, circadian rhythm entrainment, and gene expression. A landmark review in Cell from David Sinclair’s group identified the NAD+-sirtuin axis as a central regulator of aging processes, with NAD+ restoration in aged mice producing measurable reversal of age-related physiological decline.

NAD+ is also the required substrate for PARP enzymes, which repair single-strand DNA breaks that accumulate continuously from oxidative stress, UV exposure, and metabolic byproducts. Low NAD+ means slower and less complete DNA repair, which contributes to cellular aging and genomic instability over time.

The reach of NAD+ across cellular processes is what makes its decline so consequential. Beyond mitochondrial energy production, NAD+ is the substrate for sirtuins (a family of enzymes regulating gene expression, DNA repair, and stress response) and PARPs (poly-ADP-ribose polymerases that repair DNA damage). When NAD+ runs low, sirtuin activity falls, gene expression patterns shift toward stress and inflammation, and DNA repair lags behind ongoing damage. The downstream effects include accelerated cellular aging, reduced metabolic flexibility, and impaired tissue maintenance. None of this happens at one threshold; it is a continuous gradient where falling NAD+ produces measurable functional decline well before any single system fails outright.

Why NAD+ Declines With Age

The decline is not driven by a sudden loss of the ability to make NAD+. It is driven by a steady increase in how fast cells consume it. As DNA damage accumulates with age, PARP enzymes are activated more frequently, burning through NAD+ to do their repair work. CD38, an enzyme that degrades NAD+, becomes more active with age and with chronic inflammation. Cells normally recycle used nicotinamide back into active NAD+ through what is called the salvage pathway, but this recycling capacity does not keep up with the elevated consumption rate of older, more inflamed cells. The net result is that older cells are using NAD+ faster than they can replenish it, producing a deficit that compounds year over year.

Several lifestyle factors accelerate this decline beyond what age alone produces. Alcohol metabolism heavily consumes NAD+. Chronic sleep deprivation impairs the biosynthesis pathways. A sedentary lifestyle removes one of the strongest stimuli for NAD+ production, since exercise upregulates NAMPT, the rate-limiting enzyme in the primary NAD+ pathway. Chronic inflammation, obesity, and metabolic syndrome each push the depletion forward as well. The good news embedded in that list is that several of these are modifiable.

NAD+ in the Brain: Energy, Repair, and Brain Fog

The cellular consequences of NAD+ decline are not distributed evenly across the body. Some tissues feel it before others, and the brain is usually first in line. The brain consumes roughly 20 percent of the body’s oxygen and energy supply at rest, more than any other organ. That metabolic demand makes the brain disproportionately sensitive to NAD+ decline. When cellular energy production slows, the cognitive symptoms tend to show up before the physical ones do.

Many people who seek NAD+ therapy describe what they call brain fog: a subjective sense of cognitive slowing, mild memory lapses, and difficulty sustaining focus on tasks that used to feel automatic. Mechanistically, this pattern is consistent with reduced ATP production and accumulated oxidative damage in neurons. NAD+ supports the mitochondrial function and DNA repair machinery that neurons rely on heavily, and preclinical research suggests it also supports glial cell function and myelin maintenance through sirtuin pathways. Restoring NAD+ helps replenish the cellular resources the brain depends on for sustained metabolic activity.

Restoring NAD+: The Clinical Options

IV NAD+ infusions deliver NAD+ directly into the bloodstream, bypassing all conversion steps and producing the most rapid and complete restoration of cellular NAD+ pools. People typically report sharper mental clarity, improved energy, and a noticeable mood lift during or within 24 to 48 hours of an infusion. Effects from a single session are sustained for weeks to months, with significant individual variation depending on baseline depletion and lifestyle factors.

Oral NAD+ precursors, primarily NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), are converted to NAD+ through enzymatic pathways after absorption. Bioavailability is lower than IV delivery, and the increase is more gradual, but oral supplementation provides accessible daily support between infusions or as a standalone protocol.

In practice, the two delivery routes are not really competitors. People with significant baseline depletion, post-viral fatigue, heavy training loads, or cognitive symptoms that have been building for years tend to feel the difference from IV infusions faster and more decisively, which makes IV the more useful starting point in those cases. Once levels are restored, daily oral NMN or NR can hold the gains between infusions at a fraction of the cost. People who are starting from a healthier baseline and want longevity support without an immediate clinical problem to solve often do well on oral precursors alone, with periodic IV sessions added if and when energy or cognitive demands shift.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on wellness, hormone optimization, and preventive medicine. In-person care in Sugar Hill, GA, and telehealth for Georgia residents.